Intelligence Platform
Patents
Browse 2,432 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.
US 6638926
Pyrazole compounds useful as protein kinase inhibitors
expired patentUS 6635644
Inhibitors of p38
expired patentUS 6632962
Caspase inhibitors and uses thereof
expired patentUS 6632945
Inhibitors of P38
expired patentUS 6632809
Gyrase inhibitors and uses thereof
expired patentUS 6632808
Inhibitors of amyloid formation
expired patentUS 6630464
Cyclin dependent kinase (CDK)4 inhibitors and their use for treating cancer
expired patentUS 6630447
Peptide inhibitors of LFA-1/ICAM-1 interaction
expired patentUS 6624166
Pyridazines as interleukin-1&bgr; converting enzyme inhibitors
expired patentUS 6617309
Inhibitors of serine proteases, particularly hepatitis C virus NS3 protease
expired patentUS 6617331
Purine inhibitors of protein kinases, G proteins and polymerases
expired patentUS 6617350
Inhibitors of aspartyl protease
expired patentUS 6613743
Sulfonamide inhibitors of aspartyl protease
expired patentUS 6613776
Pyrazole compounds useful as protein kinase inhibitors
expired patentUS 6613764
Aspartic protease inhibitors
expired patentUS 6610684
Fused azepinone cyclin dependent kinase inhibitors
expired patentUS 6608060
Inhibitors of p38
expired patentUS 6608067
Inhibitors of serine proteases, particularly HCV NS3 protease
expired patentUS 6608087
Gyrase inhibitors and uses thereof
expired patentUS 6599873
Interleukin-1 inhibitors, compositions, and methods of treatment
expired patentUS 6596723
Fungal efflux pump inhibitors
expired patentUS 6593357
Pyrazole compositions useful as inhibitors of ERK
expired patentUS 6586475
&bgr;-amyloid protein production/secretion inhibitors
expired patentUS 6579857
Combination cancer therapy comprising adenosine and deaminase enzyme inhibitors
expired